Global private equity healthcare specialist ARCHIMED announces the acquisition of Pittsburgh, Pennsylvania-based genetic sequencing provider SeqCenter. SeqCenter’s founding scientists initially worked at the University of Pittsburgh. Frustrated with the pace, cost and difficulty of obtaining sequencing data from existing vendors and academic core laboratories, they developed their own approach to gene sequencing, ultimately leaving academia and founding SeqCenter in 2019. Today, SeqCenter is a leading service provider of a recently developed technology, Next-Generation Sequencing (NGS) that’s used for mapping the DNA and RNA information that cells use to develop and operate.
Read the full article: ARCHIMED Acquires SeqCenter, a Fast-Growing Player in Cutting-Edge DNA and RNA Gene Sequencing //
Source: https://archimed.group/news/archimed-acquires-seqcenter-a-fast-growing-player-in-cutting-edge-dna-and-rna-gene-sequencing/